Characterization of CD4+ Lymphocyte From Bone Marrow Stem Cell Using Indirect Immunofluoresence For HIV & AIDS Treatment

Purwati Purwati

Abstract views = 350 times | downloads = 257 times


Acquired immune deficiency syndrome (AIDS) is caused by Human Immunodeficiency Virus (HN). At the beginning of infection, gpl20 virus interacts with CD4 receptor at the surface of the target cell. The interaction between gpI20 and CD4 leads to the occurrence of the binding of specific chemokine receptor CXCR4 and CCR5, which are also present on the membrane of the target cell.  Therefore, CCR5 arid CXCR4 also determine the fate of the target cell.  It is the performance   of CCR5 and CXCR4, guided by controlling gene that determines susceptibility or resistance to HN infection.  Coding gene CCR5 may mutate to become protective or resistant against HTV infection. In homozygote   individuals, it tends to be resistant against infection while in heterozygote individuals it tends to be susceptible to HN infection.  Objective:  To characterize   TCD4 lymphocyte in the next that is resistant against HN infection by using gene therapy deletion 32 CCR5 to use for HTV & AIDS treatment. Method: Sample collection, mononucleated cell collection, lymphocyte culture, CD4 identification, CCR5 variance analysis, co-cultivation with PBMC HN and comparison to control. Result:  This study was performed in several steps, such as mononucleated   cell isolation, followed with cell culture, lymphocyte purification, lymphocyte and CD4 expression identification.   Conclusion:  Lymphocyte T CD4 had been mature after seven passages, once passage is about 5 days so for maturity lymphocyte T CD4 need 35 days and that cell as be candidate to resistant against HN infection by using gene therapy deletion 32 CCR5 to use for HN   & AIDS treatment.


characterization, Lymphocyte T CD4, HIV & AIDS.

Full Text:



Brooke SM, McLaughlin JR, Cortopassi KM, Sapolsky RM.2002. Effect of gpl20 on glutatione peroxidase activity in cortical cultures and the interaction with steroid hormones. J Neurochem 81: 1-24.

Dinsmore J, Ratliff J, Deacon T. 1996. Embryonic stem cell differentiated in vitro as a novel source of cells for transplantation. Cell Transplant, 5: 131- 43

Folks TM, Hart CE. l997.The Life Cycle of Human lmmunodeficiency Virus Type l. ln: AIDS. Fourth Edition. Editors: De Vita VT, Hellman S, Rosembrk SA. Lippincott - Raven, Philadelphia, pp. 29- 43

Hirschel B. 2003. HN infection. In: Infectious diseases in 30 days. Editor: Southwick FS. McGraw-Hill, Medical Publishing Division, USA, p. 477-524

Jaroslaw C, Cornelia W, Alexandra R. 2003. Potential of embryonic and adult stem cells in vitro. Biol Chem, 384: 1391- 409

Koolman J, Rohm KH .2001. Daur Hidup Virus HIV. Dalam: Atlas Berwama dan Teks Biokimia. Edisi Alih Bahasa: Wanandi SI. Editor: Sadikin. Penerbit Hipokrates, Jakarta, p. 358-359

Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon ML. 1998. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis. The Journal of Immunology. 160: 3194- 3206

Levinson W, Jawetz E. 2003. Human Immunodeficiency Virus. In: Medical Microbiology and Immunology. Seventh Edition. Editor: Levinson W, Jewetz E. International Edition. Singapore, p.286-294.

Levy JA. 1994. lntracellular Control of HIV replication. In: HIV and the Pathogenesis of AIDS. ASM press, Washington DC. p. 59—70

Luzuriaga K, Sullivan JL. 1997. Transmission of the human immunodeficiency virus from mother to the fetus and infant. In: AIDS etiology, diagnosis, reatment and prevention. Fourth Edition. Editor: De Vita VT, Hellman S, Rosenberg SA. Philadelphia, p. 167-173

Mandel GL. 2000. Human immunodeficiency virus. In: Essential atlas of infectious diseases, 2nd ed. Editor: Bleck TP, Brook I, Fekety R, Lorber B, Mildvan D. Philadelphia: Current Medicine, Inc, p.6-7.

Metcalf JA, Davey RT, Lane HC. 1997. Acquired Immunodeficiency Syndrome: Serologic and Virologic Tests. In: AIDS. Fourth Edition. Editors: De Vita VT, Hellman S, Rosernbrk SA. Lippincott- Raven, Philadelphia, p.177-195.

Money D, 2003. HIV and pregnancy. From: htm

Oppenheim JJ, Ruscetti FW. 2003. Cytokines. In: Medical immunology. Tenth ed. Editors: Parslow TG, Stites Op, Terr AI, Imboden JB International edition, San Fransisco, p. 48-166

Rantam, FA, Ferdiansyah, Nasronudin, Purwati. 2009. Stem Cells and Exploration, Airlangga University Press

Sriram B, Rammmesh A. 2008. Human embryonic stemcell (hES) derived dendritic cells are functionally normal and are suspectible to HIV-1 in. AIDS Research and Therapy

Suwendra P. 2002. Human Immunodeficiency Virus. Dalam: Buku Ajar Ilmu Kesehatan Anak infeksi dan Penyakit Tropis. Edisi pertama Editor. Soedarmo S, Gama H, Hadinegoro SR. Ikatan Dokter Anak Indonesia, Jakarta, hlm. 281-302

UNAIDS/WHO. 2000. AIDS epidemic update. Joint United Nations Programe on HIV & AIDS and World Health Organization, Genewa, p. 1-42

Viviani.B, Corsini E, Binaglia M, Galli CL, Marinovich M (2001). Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neurosdence 107: 2-24.

WHO.2002. The use of antiretrviral therapy: A simplified approach for resource- constrained countries.WHO regional office for South East Asia, New Delhi, pp. 1-49

Wolf T, Rickerts V, Staszewski S. 2007. First Case of successful allogenic stem cell transplantation in an HIV-patient who acquuuuuired severe Aplastic Anemia. Haematologica, Vol 92, Issue 4, e56-e58 doi l0.3324/haematol.l 1394

Zhang YM, Hartzell C, Narlow M. 2002. Stem cells derived cardiomyocites demonstrate arrytmic potential. Circulation, 106: 1294-99


  • There are currently no refbacks.

Copyright (c) 2020 Journal of Stem Cell Research and Tissue Engineering

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

View Stats

Creative Commons License
JSCRTE by Unair is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.